Brief: Resapp Health Says Pfizer Raises Scheme Consideration To A$0.208 Per Share

Raptor Metals

05/08/2022 08:59

Aug 5 (Reuters) - Resapp Health Ltd  RAP.AX :
    * PFIZER RAISES SCHEME CONSIDERATION TO A$0.208 PER SHARE
    * PFIZER HAS AGREED TO INCREASE SCHEME CONSIDERATION FROM
A$0.146
PER SHARE TO A$0.208 PER SHARE IN CASH
    * COURT APPROVES DISPATCH OF SUPPLEMENTARY SCHEME BOOKLET
    * REVISED SCHEME CONSIDERATION IMPLIES AN EQUITY VALUE ON A
100%
FULLY DILUTED BASIS OF APPROXIMATELY A$180 MLN
    * REVISED SCHEME CONSIDERATION IS EQUAL TO INDEPENDENT
EXPERT'S
PREFERRED VALUE OF A RESAPP SHARE
    * DIRECTORS OF RESAPP CONTINUE TO UNANIMOUSLY RECOMMEND THAT
RESAPP SHAREHOLDERS VOTE IN FAVOUR OF SCHEME

Source text for Eikon:  ID:nASX1pdXp4 
Further company coverage:  RAP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))